News
- Author:
- Sharon Worcester, MA
Publish date: February 3, 2023
In a phase 2 study, an off-the-shelf investigational therapy showed safety and efficacy against six viruses after allogeneic stem cell transplant.<...
News
- Author:
- Sharon Worcester, MA
Publish date: January 30, 2023
Pirtobrutinib for relapsed or refractory mantle cell lymphoma has been approved by the Food and Drug Administration.
News
- Author:
- Sharon Worcester, MA
Publish date: December 21, 2022
A confirmatory trial to show clinical benefit raised concerns about safety.
News
- Author:
- Sharon Worcester, MA
Publish date: November 16, 2022
Fungi were detected in all cancer types studied and were often intracellular.
News
- Author:
- Sharon Worcester, MA
Publish date: October 18, 2022
The time window for curative surgery is often short, and missing the diagnosis can result in worse clinical outcomes.
News
- Author:
- Sharon Worcester, MA
Publish date: September 30, 2022
“Our analysis provides quantifiable evidence to help providers choose lower priced, but equally effective sequences of drugs.”
News
- Author:
- Sharon Worcester, MA
Publish date: September 19, 2022
Experts are concerned that the ruling will force some individuals to pay out of pocket for preventive cancer screenings.
News
- Author:
- Sharon Worcester, MA
Publish date: September 14, 2022
This issue differs from breast implant–associated anaplastic large-cell lymphoma, a known risk among implant recipients.
News
- Author:
- Sharon Worcester, MA
Publish date: August 30, 2022
“While these findings may offer reassurance to tea drinkers, they do not indicate that people should start drinking tea or change their tea consump...
News
- Author:
- Sharon Worcester, MA
Publish date: August 23, 2022
A 2021 study found the rate of maternal mortality was almost two times higher in states that restricted abortion access compared with those that pr...
News
- Author:
- Sharon Worcester, MA
Publish date: June 30, 2022
FDA alert warns of increased risk of death and serious side affects with duvelisib, approved in 2018 to treat adults with CLL or SLL whose two prev...
News
- Author:
- Sharon Worcester, MA
Publish date: June 4, 2022
“The strategy of using ctDNA results to inform treatment almost halved the number of patients who received chemotherapy postsurgery.”
